1,199
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Should long-acting injectable antipsychotics be used earlier and more frequent in bipolar disorder, type I?

Pages 487-488 | Received 08 Nov 2021, Accepted 15 Nov 2021, Published online: 27 Nov 2021

References

  • Sletved KSO, Ziersen SC, Andersen PK, et al. Socioeconomic functioning in patients with bipolar disorder and their unaffected siblings – results from a nation-wide population-based longitudinal study. Psychol Med. 2021;9(7):1–8.
  • Kessing LV, Sondergard L, Kvist K, et al. Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study. Bipolar Disord. 2007;9(7):730–736.
  • Tohen M, Goldberg JF, Hassoun Y, et al. Identifying profiles of patients with bipolar I disorder who would benefit from maintenance therapy with a Long-Acting injectable antipsychotic. J Clin Psychiatry. 2020;81(4):OT19046AH1.
  • Yıldızhan E, Uzun E, Tomruk NB. Effect of long acting injectable antipsychotics on course and hospitalizations in bipolar disorder – a naturalistic mirror image study. Nord J Psychiatry. 2021;1–7. doi: 10.1080/08039488.2021.1931714
  • Kessing LV, Andersen PK, Vinberg M. Risk of recurrence after a single manic or mixed episode – a systematic review and Meta-analysis. Bipolar Disord. 2018;20(1):9–17.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.